These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 18845424

  • 1. Raised serum urea predicts for early death in small cell lung cancer.
    Winter MC, Potter VA, Woll PJ.
    Clin Oncol (R Coll Radiol); 2008 Dec; 20(10):745-50. PubMed ID: 18845424
    [Abstract] [Full Text] [Related]

  • 2. Early death during chemotherapy in patients with small-cell lung cancer: derivation of a prognostic index for toxic death and progression.
    Lassen UN, Osterlind K, Hirsch FR, Bergman B, Dombernowsky P, Hansen HH.
    Br J Cancer; 1999 Feb; 79(3-4):515-9. PubMed ID: 10027322
    [Abstract] [Full Text] [Related]

  • 3. High plasma D-dimer level is associated with decreased survival in patients with lung cancer.
    Altiay G, Ciftci A, Demir M, Kocak Z, Sut N, Tabakoglu E, Hatipoglu ON, Caglar T.
    Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):494-8. PubMed ID: 17513096
    [Abstract] [Full Text] [Related]

  • 4. Survival and prognostic factors in lung cancer patients treated in phase I trials: Japanese experience.
    Yamamoto N, Tamura T, Fukuoka M, Saijo N.
    Int J Oncol; 1999 Oct; 15(4):737-41. PubMed ID: 10493956
    [Abstract] [Full Text] [Related]

  • 5. Serum p53 antibodies: predictors of survival in small-cell lung cancer?
    Murray PV, Soussi T, O'Brien ME, Smith IE, Brossault S, Norton A, Ashley S, Tavassoli M.
    Br J Cancer; 2000 Dec; 83(11):1418-24. PubMed ID: 11076647
    [Abstract] [Full Text] [Related]

  • 6. High pretreatment serum concentration of basic fibroblast growth factor is a predictor of poor prognosis in small cell lung cancer.
    Ruotsalainen T, Joensuu H, Mattson K, Salven P.
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1492-5. PubMed ID: 12433733
    [Abstract] [Full Text] [Related]

  • 7. Markov model and markers of small cell lung cancer: assessing the influence of reversible serum NSE, CYFRA 21-1 and TPS levels on prognosis.
    Boher JM, Pujol JL, Grenier J, Daurès JP.
    Br J Cancer; 1999 Mar; 79(9-10):1419-27. PubMed ID: 10188885
    [Abstract] [Full Text] [Related]

  • 8. Bcl-2 expression as a predictor of chemosensitivities and survival in small cell lung cancer.
    Takayama K, Ogata K, Nakanishi Y, Yatsunami J, Kawasaki M, Hara N.
    Cancer J Sci Am; 1996 Mar; 2(4):212-6. PubMed ID: 9166534
    [Abstract] [Full Text] [Related]

  • 9. Limited small-cell lung cancer: do favorable short-term results predict ultimate outcome?
    Armstrong J, Shank B, Scher H, Gaynor J, Martini N, Kutcher J, Kris M.
    Am J Clin Oncol; 1991 Aug; 14(4):285-90. PubMed ID: 1650527
    [Abstract] [Full Text] [Related]

  • 10. Does maintenance/consolidation chemotherapy have a role in the management of small cell lung cancer (SCLC)? A metaanalysis of the published controlled trials.
    Bozcuk H, Artac M, Ozdogan M, Savas B.
    Cancer; 2005 Dec 15; 104(12):2650-7. PubMed ID: 16284984
    [Abstract] [Full Text] [Related]

  • 11. Significance of serum neuron-specific enolase as a predictor of relapse of small cell lung cancer.
    Nitta T, Fukuoka M, Masuda N, Kusunoki Y, Matsui K, Kudoh S, Hirashima T, Yana T, Ito K, Takada M.
    Jpn J Clin Oncol; 1995 Oct 15; 25(5):179-83. PubMed ID: 7474404
    [Abstract] [Full Text] [Related]

  • 12. [Value of C-reactive protein determination in small cell lung cancer].
    Arpin D, Trillet-Lenoir V, Lasset C, Souquet PJ, Riou R, Yoanidis I, Guidollet J, Cordier JF, Brune J.
    Bull Cancer; 1993 Dec 15; 80(12):1063-8. PubMed ID: 8081044
    [Abstract] [Full Text] [Related]

  • 13. Detection of occult tumor cells in peripheral blood from patients with small cell lung cancer by promoter methylation and silencing of the retinoic acid receptor-beta.
    Oshita F, Sekiyama A, Suzuki R, Ikehara M, Yamada K, Saito H, Noda K, Miyagi Y.
    Oncol Rep; 2003 Dec 15; 10(1):105-8. PubMed ID: 12469153
    [Abstract] [Full Text] [Related]

  • 14. Serum pseudouridine as a biochemical marker in small cell lung cancer.
    Tamura S, Fujioka H, Nakano T, Hada T, Higashino K.
    Cancer Res; 1987 Nov 15; 47(22):6138-41. PubMed ID: 2822241
    [Abstract] [Full Text] [Related]

  • 15. Predictive and prognostic factors in small cell lung carcinoma (SCLC)--analysis from routine clinical practice.
    Brueckl WM, Herbst L, Lechler A, Fuchs F, Schoeberl A, Zirlik S, Klein P, Brunner TB, Papadopoulos T, Hohenberger W, Hahn EG, Wiest GH.
    Anticancer Res; 2006 Nov 15; 26(6C):4825-32. PubMed ID: 17214347
    [Abstract] [Full Text] [Related]

  • 16. Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer.
    De Ruysscher D, Pijls-Johannesma M, Bentzen SM, Minken A, Wanders R, Lutgens L, Hochstenbag M, Boersma L, Wouters B, Lammering G, Vansteenkiste J, Lambin P.
    J Clin Oncol; 2006 Mar 01; 24(7):1057-63. PubMed ID: 16505424
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Soluble Fas and Fas ligand provide new information on metastasis and response to chemotherapy in SCLC patients.
    Shimizu M, Kondo M, Ito Y, Kume H, Suzuki R, Yamaki K.
    Cancer Detect Prev; 2005 Mar 01; 29(2):175-80. PubMed ID: 15829378
    [Abstract] [Full Text] [Related]

  • 19. Increased expression of integrin beta1 is a poor prognostic factor in small-cell lung cancer.
    Oshita F, Kameda Y, Ikehara M, Tanaka G, Yamada K, Nomura I, Noda K, Shotsu A, Fujita A, Arai H, Ito H, Nakayama H, Mitsuda A.
    Anticancer Res; 2002 Mar 01; 22(2B):1065-70. PubMed ID: 12168902
    [Abstract] [Full Text] [Related]

  • 20. [Clinical significance of ProGRP31-98 in patients with small-cell lung cancer].
    Yang J, Li R, Li A.
    Zhonghua Zhong Liu Za Zhi; 2000 May 01; 22(3):216-8. PubMed ID: 11778234
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.